You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-DR4 antibody (ab8415)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-DR4 antibody
See all DR4 products (12) ...

Description

Rabbit polyclonal to DR4

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide: ASGTEAAAATPSKVWGSSAG, corresponding to amino acids 24/43 of Human DR4 (Peptide available as ab8447 .)

ASGTEAAAATPSKVWGSSAG

Positive control

HeLa or Jurkatwhole cell lysate A 57 kDa band should be detected.

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

PBS with 0.02% sodium azide

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Polyclonal

Isotype

IgG

Light chain type

unknown

  • Western blot - DR4 antibody (ab8415)Western blot - DR4 antibody (ab8415) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab8415 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF-kappa-B.

Tissue specificity

Widely expressed. High levels are found in spleen, peripheral blood leukocytes, small intestine and thymus, but also in K562 erythroleukemia cells, MCF7 breast carcinoma cells and activated T-cells.

Sequence similarities

Contains 1 death domain.
Contains 3 TNFR-Cys repeats.

Cellular localization

Membrane.

Target information above from: UniProt accessionO00220 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Apo 2 antibody
  • Apo2 antibody
  • CD 261 antibody
  • CD261 antibody
  • CD261 antigen antibody
  • Cytotoxic ligand TRAIL receptor antibody
  • Cytotoxic TRAIL receptor antibody
  • Death receptor 4 antibody
  • DR 4 antibody
  • DR4 antibody
  • MGC9365 antibody
  • NF related apoptosis-inducing ligand receptor 1 antibody
  • T10A antibody
  • TNF related apoptosis inducing ligand receptor 1 antibody
  • TNF-related apoptosis-inducing ligand receptor 1 antibody
  • TNFRSF10A antibody
  • TR10A_HUMAN antibody
  • TRAIL R1 antibody
  • TRAIL receptor 1 antibody
  • TRAIL-R1 antibody
  • TRAILR 1 antibody
  • TRAILR1 antibody
  • Tumor necrosis factor receptor superfamily member 10a antibody
  • Tumor necrosis factor receptor superfamily member 10A precursor antibody
see all

Anti-DR4 antibody images:

  Western blot - DR4 antibody (ab8415)

Western blot - DR4 antibody (ab8415)

All lanes : Anti-DR4 antibody (ab8415)

Lane 1 : H: HeLa
Lane 2 : K: K562
Lane 3 : J: Jurkat whole cell lysate


Observed band size : 57 kDa (why is the actual band size different from the predicted?)


Western blot analysis of DR4 at 1:500 dilution.

References for Anti-DR4 antibody (ab8415)

This product has been referenced in:

  • Köhler B  et al. Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects. PLoS ONE 3:e2844 (2008). WB; Human.Read more (PubMed: 18665234) »

See 1 publication for this product

Publishing research using ab8415? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"